Search results
Author(s):
Andrew Holden
Added:
2 weeks ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II…
View more
Author(s):
Angela McInerney
,
Seán O Hynes
,
Nieves Gonzalo
Added:
3 months ago
Author(s):
Rodrigo Bagur
,
Angela McInerney
,
Rolf Kreutz
,
et al
Added:
2 weeks ago
This webinar brings together leading experts Dr Rodrigo Bagur, Dr Angela McInerney, Dr Rolf Kreutz, Dr Sohail Khan, Dr Sophia Khattak, Dr Jonathan Hinton and Dr Peter O’Kane to explore the challenges and solutions in managing calcified coronary artery disease. The session will provide a detailed examination of coronary calcification from pathological and clinical perspectives, including…
View more
Author(s):
Nouf Alanazi
,
Alaide Chieffo
,
Added:
1 week ago
TCT Middle East 2025 — We are joined by Dr Nouf Alanazi, Dr Alaide Chieffo and Dr Nadia Sutton as they discuss key takeaways from the conference for the physiological assessment of coronary artery disease.The panel explores emerging paradigms in MINOCA and INOCA management, addressing the limitations of conventional approaches. They review current guideline recommendations for functional testing…
View more
Author(s):
Rodrigo Bagur
,
Angela McInerney
,
Rolf Kreutz
,
et al
Start date:
Apr 23, 2025
This webinar brings together leading experts Dr Rodrigo Bagur, Dr Angela McInerney, Dr Rolf Kreutz, Dr Sohail Khan, Dr Sophia Khattak, Dr Jonathan Hinton and Dr Peter O’Kane to explore the challenges and solutions in managing calcified coronary artery disease. The session will provide a detailed examination of coronary calcification from pathological and clinical perspectives, including…
View more
Author(s):
Ajay J Kirtane
Added:
6 months ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott…
View more
Author(s):
Michelle C Morris
,
Rolf P Kreutz
Added:
1 month ago
Author(s):
Duy Cao Phuong Le
,
Hoa The Bui
,
Quan Duy Vo
Added:
11 months ago
Author(s):
Khaled A Shams
,
Hossameldin Hussein
,
Soha Romeih
,
et al
Added:
8 months ago
Author(s):
Mahmoud Izraiq
,
Nail Alshoubaki
,
Omran A Abu-Dhaim
,
et al
Added:
5 months ago